The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents

Carlos Zamora, Geòrgia Anguera, M. Riudavets Melià, Letícia Alserawan De Lamo, Ivana Sullivan, A. Barba Joaquín, J. Serra López, Ma Àngels Ortiz, Maria Mulet, Sílvia Vidal, Margarita Majem